Method Validation Study for SARS-CoV-2 Viral RNA Detection in Cervical, Rectal, Amniotic Fluid, Placental, Umbilical Cord Blood, and Breastmilk Specimens in a Cohort of Unvaccinated Women in Manila, Philippines
- PMID: 39308885
- PMCID: PMC11413462
- DOI: 10.47895/amp.vi0.7618
Method Validation Study for SARS-CoV-2 Viral RNA Detection in Cervical, Rectal, Amniotic Fluid, Placental, Umbilical Cord Blood, and Breastmilk Specimens in a Cohort of Unvaccinated Women in Manila, Philippines
Abstract
Objectives: To validate a method in detecting SARS-CoV-2 via RT-qPCR in pregnant and non-pregnant samples other than nasopharyngeal swabs and/or oropharyngeal swabs such as cervical, rectal, amniotic fluid, placental, umbilical cord blood, and breastmilk.
Methods: We performed a validation experiment using MGI easy extraction kits and BGI PCR kits on non-conventional specimens, including cervical, rectal, amniotic fluid, placental, umbilical cord blood, and breastmilk to detect and confirm the presence of SARS-CoV-2. In addition, we tested the validated method on 572 purposively sampled field-collected non-conventional specimens from a cohort of 109 unvaccinated pregnant and 47 unvaccinated non-pregnant women to assess which candidate non-conventional maternal- and fetal-associated specimens may contribute to maternal-fetal viral vertical transmission.
Results: Positive detection of SARS-CoV-2 viral RNA in non-conventional specimens was demonstrated and verified. Of the 572 non-conventional samples tested, 1.8% (10/572) were positively validated by RT-qPCR for SARS-CoV-2 in the maternal-associated specimens particularly the rectal (5), placental (1), and cervical (4) swabs among six pregnant and four non-pregnant individuals. In contrast, no SARS-CoV-2 viral RNA was detected in fetal-associated specimens.
Conclusion: The results of the validation study may serve as an additional diagnostic screening layer to support maternal-child care. Furthermore, viral detection in these non-conventional maternal specimens may also be utilized to provide guidance in the clinical management of neonates, and pregnant women during delivery.
Keywords: PCR; Philippines; SARS-CoV-2; amniotic fluid; breastmilk; placenta; pregnant women; umbilical cord.
© 2024 Acta Medica Philippina.
Conflict of interest statement
All authors declared no conflicts of interest.
References
-
- WHO Coronavirus (COVID-19) Dashboard [Internet]. 2022. [cited 2022 Nov]. Available from: https://covid19.who.int/.
-
- Department of Health , COVID-19 Tracker [Internet]. 2021. [cited 2021 Jun]. Available from: https://doh.gov.ph/covid19tracker.
-
- Centers for Disease Control and Prevention, American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine . Special Considerations During Pregnancy and After Delivery [Internet]. 2023. [cited 2023 Feb]. Available from: https://files.covid19treatmentguidelines.nih.gov/guidelines/section/sect...
LinkOut - more resources
Full Text Sources
Miscellaneous